Sub Heading

Clinical Trials Details

Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

IRB Protocol Number
S2013

Clinical Trial Categories

  • Solid Tumors
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Adults who will be getting an immune checkpoint inhibitor as standard treatment for a solid tumor cancer and can complete study surveys in English, Spanish, or French

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.